Navigation Links
Women Win Legal Battle Over Treatment Of Breast Cancer

For many hundreds of women’s fight against the cancer of breast the ruling by the courts has opened means of treatment. Three senior Court of Appeal judges said // yesterday that the policy adopted by the Swindon NHS Primary Care Trust, of funding treatment with the drug Herceptin only in "exceptional circumstances", was irrational because it was not supported by any personal or clinical distinctions among eligible patients. The trust itself had insisted that financial considerations did not underlie its policy.

Ann Marie Rogers, a breast cancer patient, has won a landmark ruling that her local hospital acted unlawfully in refusing to supply her with a potentially life-saving treatment.

Jeremy Hughes, the chief executive of Breakthrough Breast Cancer, welcoming the judgment, said that, it could be hoped that this would send out clear messages to all PCTs, that Herceptin should be prescribed on the basis of clinical need, not cost. Herceptin is already being licensed for use in women with advanced breast cancer, and studies show that it may also be effective in preventing a recurrence of early-stage forms of the disease. The makers, of the drug, Roche, have claimed to have applied for a licence for early-stage treatment with Herceptin and the National Institute for Clinical Excellence has agreed to fast-track its appraisal of which patients should receive it on the NHS, but these two decisions are not expected until later this year. Till such time the PCTs have been told to act at their own discretion, and this has lead to widespread disparities in who receives the drug. It has been found in survey that only 10 % of eligible patients in some areas are given access to Herceptin, compared to 90% in others.

The ruling stated that it is now a matter for the PCT to reconsider its policy and to formulate a lawful policy upon which to base decisions in particular cases. The chief executive of Swindon Primary Care Trust, said, that they we lcome the clarity given by the court on the use of Herceptin. He stated that with this new judgment they would now include and restructure their policy by taking into consideration the points made by the court. The PCT will continue to treat all patients now and in the future with care and consideration, he said.

Meanwhile the Dr David Miles The British breast cancer expert who helped develop Herceptin last night criticised the growing hype over the so-called wonder drug. In his statement after the court ruling he said that a wonder drug is something that cures everyone who takes it with very few problems. Explaining that it is clearly not the case with Herceptin. He explained that people think that it would halve the rate of recurrence of cancer, but it wouldn’t be so impressive when people understand that there could be maybe a fall from 20% to 10%.

His concerns were echoed by other senior doctors, among them Joe Collier, the professor of medicines policy at St George's Hospital Medical School, London, and David Kerr, professor of clinical pharmacology and cancer therapy at Oxford University.


'"/>




Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier this year ... former overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, ... for the most career rushing yards by a quarterback (6,109) and the most rushing ...
(Date:4/24/2017)... ... 24, 2017 , ... Ridgecrest Herbals makes it a point to lead the ... waste, and support renewable energy. They believe this is a crucial part of their ... for health issues, and maintain that destroying the environment in the pursuit of profit ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... Research Association’s Outstanding Public Communication of Education Research Award. The award honors scholars ... education communities. It recognizes a scholar who has demonstrated the capacity to deepen ...
(Date:4/24/2017)... ... ... Today, Bright Pink , a national non-profit organization focusing on the prevention and early ... Bright Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In ... as Chairman of the Board and launched a national search to find a visionary new ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the ... Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than ... marketer in the last 25 years. , Now, due to changes in the broadcast ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Global Surgical Drainage Device Market: Overview ... to remove excess liquid and air. The fluid to ... or lymph. Surgical drains are used in a wide ... surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common use ... accumulation of fluid e.g. blood or pus. Surgical drains ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), a ... Uro/Gyn and Gynecology markets with innovative and proprietary products, ... March 31, 2017 after the market close on Tuesday, ... host a conference call and webcast to discuss its ... 2017 at 4:30 p.m. Eastern Time (3:30 p.m. Central ...
Breaking Medicine Technology: